Intervention Review

Cyclophosphamide for multiple sclerosis

  1. Loredana La Mantia1,*,
  2. Clara Milanese1,
  3. Nerina Mascoli1,
  4. Roberto D'Amico2,
  5. Bianca Weinstock-Guttman3

Editorial Group: Cochrane Multiple Sclerosis Group

Published Online: 24 JAN 2007

Assessed as up-to-date: 14 NOV 2006

DOI: 10.1002/14651858.CD002819.pub2

How to Cite

La Mantia L, Milanese C, Mascoli N, D'Amico R, Weinstock-Guttman B. Cyclophosphamide for multiple sclerosis. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD002819. DOI: 10.1002/14651858.CD002819.pub2.

Author Information

  1. 1

    Fondazione I.R.C.C.S. - Istituto Neurologico C. Besta, MS Group, Milano, Italy

  2. 2

    University of Modena and Reggio Emilia, Department of Oncology and Hematology, Modena, Italy

  3. 3

    The Jacobs Neurological Institute, State University of New York at Buffalo, Baird MS Center, Buffalo, New York, USA

*Loredana La Mantia, MS Group, Fondazione I.R.C.C.S. - Istituto Neurologico C. Besta, Via Celoria, 11, Milano, 20133, Italy.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 24 JAN 2007


Cited in:


This article has been cited by:

  1. 1
    Daniel Ontaneda, Robert J Fox, Jeremy Chataway, Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives, The Lancet Neurology, 2015, 14, 2, 208


  2. 2
    N. Melzer, S. G. Meuth, Disease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: common and divergent current and future strategies, Clinical & Experimental Immunology, 2014, 175, 3
  3. 3
    Martin Häusler, Christos P. Panteliadis, Neuropädiatrie, 2014,


  4. 4
    Paul W. O’Connor, Jiwon Oh, Multiple Sclerosis and Related Disorders, 2014,


  5. 5
    Aaron Boster, Gilles Edan, Elliott Frohman, Adil Javed, Olaf Stuve, Alexandros Tselis, Howard Weiner, Bianca Weinstock-Guttman, Omar Khan, Intense immunosuppression in patients with rapidly worsening multiple sclerosis: treatment guidelines for the clinician, The Lancet Neurology, 2008, 7, 2, 173


  6. You have free access to this content6
    Graziella Filippini, Cinzia Del Giovane, Laura Vacchi, Roberto D'Amico, Carlo Di Pietrantonj, Deirdre Beecher, Georgia Salanti, Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis, The Cochrane Library,